Brain ischemia and ischemic blood-brain barier as etiological factors in sporadic Alzheimer's disease

Neuropsychiatric Disease and Treatment

Volumn 4, Issue 5, 2008, Pages 855-864

  Pluta, Ryszard ^a   Ułamek, Marzena ^a  

^a POLISH ACADEMY OF SCIENCES   (Poland)

Author keywords

Alzheimer's disease; Amyloid plaques; Brain ischemia; Dementia; Ischemic blood brain barrier; Leukocytes; Neuronal death; Platelets

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN E; BETA SECRETASE; CLUSTERIN; ESTROGEN; GAMMA SECRETASE;

ALZHEIMER DISEASE; ASTROCYTE; BLOOD BRAIN BARRIER; BRAIN ISCHEMIA; CELL DEATH; ENDOTHELIUM CELL; EPENDYMA CELL; GENDER; HORMONE ACTION; HUMAN; IMMUNOREACTIVITY; MENOPAUSE; MICROGLIA; MICROVASCULAR ISCHEMIA; NEUROPATHOLOGY; OLIGODENDROGLIA; PERICYTE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; SPORADIC ALZHEIMER DISEASE;

EID: 56849119259     PISSN: 11766328     EISSN: None     Source Type: Journal    
DOI: 10.2147/ndt.s3739     Document Type: Review

References (109)

1. Abramov AY, Canevari L, Duchen MR. 2003. Changes in intracellular calcium and glutathione in astrocytes as the primary mechanism of amyloid neurotoxicity. J Neurosci, 23:5088-95.
2. Alzheimer A. 1907. [Über eine eigenartige Erkrankung der Himrinde.] Allg Z Psychiatr Psych Gericht Med (Berlin), 64:146-8.
3. Anfuso CD, Assero G, Lupo G, et al. 2004. Amyloid beta (1-42) and its beta (25-35) fragment induce activation and membrane translocation of cytosolic phospholipase A (2) in bovine retina capillary pericytes. Biochem Biophys Acta, 1686:125-38.
4. Arshavsky YL. 2006. Alzheimer's disease, brain immune privilege and memory: A hypothesis. J Neural Transm, 113:1697-707.
5. Attems J, Jellinger KA. 2004. Only cerebral capillary amyloid angiopathy correlates with Alzheimer pathology - a pilot study. Acta Neuropathol, 107:83-90.
6. Atwood CS, Obrenovich ME, Liu T, et al. 2003a. Amyloid-beta: a chameleon walking in two worlds: a review of the trophic and toxic properties of amyloid-β. Brain Res Brain Res Rev, 43:1-16.
7. Atwood CS, Bowen RL, Smith MA, et al. 2003b. Cerebrovascular requirement for sealant, anti-coagulant and remodeling molecules that allow for the maintenance of vascular integrity and blood supply. Brain Res Brain Res Rev, 43:164-78.
8. Badan I, Dinca I, Buchhold B, et al. 2004. Accelerated accumulation of N- and C-terminal beta APP fragments and delayed recovery of microtubule-associated protein 1B expression following stroke in aged rats. Eur J Neurosci, 19:2270-80.
9. Bailey TL, Rivara CB, Rocher AB, et al. 2004. The nature and effects of cortical microvascular pathology in aging and Alzheimer's disease. Neurol Res, 26:573-8.
10. Banati RB, Gehrmann J, Wießner C, et al. 1995. Glial expression of the β-amyloid precursor protein (APP) in global ischemia. J Cereb Blood Flow Metab, 15:647-54.
11. Bernaudin M, Nouvelot A, MacKensie ET, et al. 1998. Selective neuronal vulnerability and specific glial reactions in hippocampal and neocortical organotypic cultures submitted to ischemia. Exp Neurol, 150:30-9.
12. Butler TL, Kassed CA, Sanberg PR, et al. 2002. Neurodegeneration in the rat hippocampus and striatum after middle cerebral artery occlusion. Brain Res, 929:252-60.
13. Caceres MJ, Schleien CL, Kuluz JW, et al. 1995. Early endothelial damage and leukocyte accumulation in piglet brains following cardiac arrest. Acta Neuropathol, 90:582-91.
14. Chen M, Inestrosa NC, Ross GS, et al. 1995. Platelets are the primary source of amyloid-β peptide in human blood. Biochem Biophys Res Commun, 213:96-103.
15. Chen J, Xu W, Jiang H. 2001. 17beta-estradiol protects neurons from ischemic damage and attenuates accumulation of extracellular excitatory amino acids. Anesth Analg, 92:1520-3.
16. Chi OZ, Liu X, Weiss HR. 2002. Effects of 17beta-estradiol on blood-brain barrier disruption during focal ischemia in rats. Horm Metab Res, 34:530-4.
17. Chi OZ, Hunter C, Liu X, et al. 2005. Effects of 17beta-estradiol on blood-brain barrier disruption in focal ischemia during GABA (A) receptor inhibition. Horm Metab Res, 37:209-13.
18. D'Andrea MR, Cole GM, Ard MD. 2004. The microglial phagocytic role with specific plaque types in the Alzheimer disease brain. Neurobiol Aging, 25:675-83.
19. D'Andrea MR. 2005. Add Alzheimer's disease to the list of autoimmune diseases. Med Hypotheses, 64:458-63.
20. Deane R, Du Yan S, Submamaryan RK, et al. 2003. RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain. Nat Med, 9:907-13.
21. Dede DS, Yavuz B, Yavuz BB, et al. 2007. Assessment of endothelial function in Alzheimer's disease: is Alzheimer's disease a vascular disease? J Am Geriatr Soc, 55:1613-7.
22. Dickstein DL, Biron KE, Ujiie M, et al. 2006. Aβ peptide immunization restores blood-brain barrier integrity in Alzheimer disease. FASEB J, 20:426-33.
23. Dubal DB, Kashon ML, Pettigrew LC, et al. 1998. Estradiol protects against ischemic injury. J Cereb Blood Flow Metab, 18:1253-8.
24. Erusalimsky JD, Kurz DJ. 2005. Cellular senescence in vivo: its relevance in aging and cardiovascular disease. Exp Gerontol, 40:634-42.
25. Farkas IG, Czigner A, Farkas E, et al. 2003. Beta-amyloid peptide-induced blood-brain barrier disruption facilitates T-cell entry into the rat brain. Acta Histochem, 105:115-25.
26. Fiala M, Zhang L, Gan X, et al. 1998. Amyloid-beta induces chemokine secretion and monocyte migration across a human blood-brain barrier model. Mol Med, 4:480-9.
27. Gartshore G, Patterson J, Macrae IM. 1997. Influence of ischemia and reperfusion on the course of brain tissue swelling and blood-brain barrier permeability in a rodent model of transient focal cerebral ischemia. Exp Neurol, 147:353-60.
28. Gidday JM, Gasche YG, Copin JC, et al. 2005. Leukocyte-derived matrix metalloproteinase-9 mediates blood-brain barrier breakdown and is proinflammatory after transient focal cerebral ischemia. Am J Physiol Heart Circ Physiol, 289:H558-68.
29. Grammas P. 2000. A damaged microcirculation contributes to neuronal cell death in Alzheimer's disease. Neurobiol Aging, 21:199-205.
30. Humpel C, Marksteiner J. 2005. Cerebrovascular damage as a cause for Alzheimer's disease. Curr Neurovasc Res, 2:341-7.
31. Ishikawa, M, Cooper D, Arumugam TV, et al. 2004. Platelet-leukocyte-endothelial cell interactions after middle cerebral artery occlusion and reperfusion. J Cereb Blood Flow Metab, 24:907-15.
32. Ishimaru H, Ishikawa K, Haga S, et al. 1996. Accumulation of apolipoprotein E and β-amyloid-like protein in a trace of the hippocampal CA1 pyramidal cell layer after ischaemic delayed neuronal death. NeuroReport, 7:3063-7.
33. Iwasaki K, Egashira N, Hatip-Al-Khatib I, et al. 2006. Cerebral ischemia combined with beta-amyloid impairs spatial memory in the eight-arm radial maze task in rats. Brain Res, 1097:216-23.
34. Jendroska K, Poewe W, Daniel SE, et al. 1995. Ischemic stress induces deposition of amyloid beta immunoreactivity in human brain. Acta Neuropathol, 90:461-6.
35. Kalaria RN. 1999. The blood-brain barrier and cerebrovascular pathology in Alzheimer's disease. Ann NY Acad Sci, 893:113-25.
36. Kalaria RN. 2000. The role of cerebral ischemia in Alzheimer's disease. Neurobiol Aging, 21321-30.
37. Kalaria RN. 2002. Small vessel disease and Alzheimer's dementia: Pathological considerations. Cerebrovasc Dis, 13(Suppl 2):48-52.
38. Kang HS, Ahn HS, Kang HJ, et al. 2006. Effect of estrogen on the expression of occludin in ovariectomized mouse brain. Neurosci Lett, 402:30-4.
39. Kawai M, Kalaria RN, Harik SI, et al. 1990. The relationship of amyloid plaques to cerebral capillaries in Alzheimer's disease. Am J Pathol, 137:1435-46.
40. Kida E, Pluta R, Lossinsky AS, et al. 1995. Complete cerebral ischemia with short-term survival in rat induced by cardiac arrest. II. Extracellular and intracellular accumulation of apolipoproteins E and J in the brain. Brain Res, 674:341-6.
41. Koistinaho M, Kettunen MI, Goldsteins G, et al. 2002. Beta-amyloid precursor protein transgenic mice that harbor diffuse A beta deposits but do not form plaques show increased ischemic vulnerability: role of inflammation. Proc Natl Acad Sci U S A, 99:1610-5.
42. Koistinaho M, Lin S, Wu X, et al. 2004. Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-β peptides. Nat Med, 10:719-26.
43. Lippoldt A, Kniesel U, Liebner, S, et al. 2000. Structural alterations of tight junctions are associated with loss of polarity in stroke-prone spontaneously hypertensive rat blood-brain barrier endothelial cells. Brain Res, 885:251-61.
44. Lupo G, Anfuso CD, Assero G, et al. 2001. Amyloid β (1-42) and its β (25-35) fragment induce in vitro phosphatidylcholine hydrolysis in bovine retina capillary pericytes. Neurosci Lett, 303:185-8.
45. Malm TM, Koistinaho M, Parepalo M, et al. 2005. Bone-marrow-derived cells contribute to the recruitment of microglial cells in response to beta-amyloid deposition in APP/PS1 double transgenic Alzheimer mice. Neurobiol Dis, 18:134-42.
46. Matsunaga W, Shirokawa T, Isobe K. 2003. Specific uptake of Abeta 1-40 in rat brain occurs in astrocyte, but not in microglia. Neurosci Lett, 342:129-31.
47. McCullough LD, Alkayed NJ, Traystman RJ, et al. 2001 Postischemic estrogen reduces hypoperfusion and secondary ischemia after experimental stroke. Stroke, 32:796-802.
48. Mehta PD, Pirttila T. 2002. Biological markers of Alzheimer's disease. Drug Dev Res, 56:74-84.
49. Minamino T, Miyauchi H, Yoshida T, et al. 2004. Vascular cell senescence and vascular aging. J Mol Cell Cardiol, 36:175-83.
50. Mossakowski MJ, Lossinsky AS, Pluta R, et al. 1993. Changes in cerebral microcirculation system following experimentally induced cardiac arrest: a SEM and TEM study. In: Tomita M (ed). Microcirculatory stasis in the brain. Amsterdam: Elsevier Science Publishers BV, pp. 99-106.
51. Mossakowski MJ, Lossinsky AS, Pluta R, et al. 1994. Abnormalities of the blood-brain barrier in global cerebral ischemia in rats due to experimental cardiac arrest. Acta Neurochir Suppl (Wien), 60:274-6.
52. Nimmo AJ, Cernak I, Heath DL, et al. 2004. Neurogenic inflammation is associated with development of edema and functional deficits following traumatic brain injury in rats. Neuropeptides, 38:40-7.
53. Nishijima K, Kiryu J, Tsujikawa A, et al, 2004. Platelets adhering to the vascular wall mediate postischemic leukocyte-endothelial cell interactions in retinal microcirculation. Invest Ophthalmol Vis Sci, 45:977-84.
54. Niwa K, Younkin L, Ebeling C, et al. 2000. Abeta 1-40-related reduction in functional hyperemia in mouse neocortex during somatosensory activation. Proc Natl Acad Sci U S A, 97:9735-40.
55. Ohtake M, Morino S, Kaidoh T, et al. 2004. Three-dimensional structural changes in cerebral microvessels after transient focal cerebral ischemia in rats: Scanning electron microscopic study of corrosion casts. Neuropathology, 24:219-27.
56. Palacios G, Mengod G, Tortosa A, et al. 1995. Increased β-amyloid precursor protein expression in astrocytes in the gerbil hippocampus following ischaemia: Association with proliferation of astrocytes. Eur J Neurosci, 7:501-10.
57. Paris D, Patel N, DelleDonne A, et al. 2004a. Impaired angiogenesis in a transgenic mouse model of cerebral amyloidosis. Neurosci Lett, 366:80-5.
58. Paris D, Townsend K, Quadros A, et al. 2004b. Inhibition of angiogenesis by Aβ peptides. Angiogenesis, 7:75-85.
59. Pennypacker KR, Hernandez H, Benkovic S, et al. 1999. Induction of presenilins in the rat brain after middle cerebral arterial occlusion. Brain Res Bull, 48:539-43.
60. Petito CK, Pulsinelli WA, Jacobson G, et al. 1982. Edema and vascular permeability in cerebral ischemia: comparison between ischemic neuronal damage and infarction. J Neuropathol Exp Neurol, 41:423-36.
61. Pluta R, Lossinsky AS, Mossakowski MJ, et al. 1991. Reassessment of new model of complete cerebral ischemia in rats. Method of induction of clinical death, pathophysiology and cerebrovascular pathology. Acta Neuropathol, 83:1-11.
62. Pluta R, Lossinsky AS, Wisniewski HM, et al. 1994a. Early blood-brain barrier changes in the rat following transient complete cerebral ischemia induced by cardiac arrest. Brain Res, 633:41-52.
63. Pluta R, Kida E, Lossinsky AS, et al. 1994b. Complete cerebral ischemia with short-term survival in rats induced by cardiac arrest. I. Extracellular accumulation of Alzheimer's β-amyloid protein precursor in the brain. Brain Res, 649:323-8.
64. Pluta R, Lossinsky AS, Walski M, et al. 1994c. Platelet occlusion phenomenon after short- and long-term survival following complete cerebral ischemia in rats produced by cardiac arrest. J Brain Res, 35:463-71.
65. Pluta R, Barcikowska M, Januszewski S, et al. 1996. Evidence of blood-brain barrier permeability/leakage for circulating human Alzheimer's β-amyloid-(1-42)-peptide. NeuroReport, 7:1261-5.
66. Pluta R, Misicka A, Januszewski S, et al. 1997a. Transport of human β-amyloid peptide through the rat blood-brain barrier after global cerebral ischemia. Acta Neurochir Suppl, 70:247-9.
67. Pluta R, Barcikowska M, Kida. E, et al. 1997b. Late extracellular deposits of β-amyloid precursor protein in ischaemic rat brain show different immunoreactivity to the N- and C-terminal. Alzheimer's Res, 3:51-7.
68. Pluta R, Barcikowska M, Misicka A, et al. 1999. Ischemic rats as a model in the study of the neurobiological role of human β-amyloid peptide. Time-dependent disappearing diffuse amyloid plaques in brain. NeuroReport, 10:3615-9.
69. Pluta R. 2000. The role of apolipoprotein E in the deposition of β-amyloid peptide during ischemia-reperfusion brain injury. A model of early Alzheimer's disease. Ann NY Acad Sci, 903:324-34.
70. Pluta R, Misicka A, Barcikowska M, et al. 2000. Possible reverse transport of β-amyloid peptide across the blood-brain barrier. Acta Neurochir Suppl, 76:73-7.
71. Pluta R. 2001. Proteins associated with Alzheimer's disease in conditions predisposing to Alzheimer's-type neurodegeneration. J Cereb Blood Flow Metab, 21(Suppl 1):S424.
72. Pluta R. 2002a. Glial expression of the beta-amyloid peptide in cardiac arrest. J Neurol Sci, 203-204:277-80.
73. Pluta R. 2002b. Astroglial expression of the beta-amyloid in ischemia-reperfusion brain injury. Ann NY Acad Sci, 977:102-8.
74. Pluta R. 2003. Blood-brain barrier dysfunction and amyloid precursor protein accumulation in microvascular compartment following ischemia-reperfusion brain injury with 1-year survival. Acta Neurochir Suppl, 86:117-22.
75. Pluta R. 2004a. Alzheimer lesions after ischemia-reperfusion brain injury. Folia Neuropathol, 42:181-6.
76. Pluta R. 2004b. From brain ischemia-reperfusion injury to possible sporadic Alzheimer's disease. Curr Neurovasc Res, 1:441-53.
77. Pluta R. 2005. Pathological opening of the blood-brain barrier to horseradish peroxidase and amyloid precursor protein following ischemia-reperfusion brain injury. Chemotherapy, 51:223-6.
78. Pluta R. 2006a. Ischemia-reperfusion factors in sporadic Alzheimer's disease. In: Welsh EM (ed). New research on Alzheimer's disease. New York: Nova Science Publishers, pp. 183-234.
79. Pluta R. 2006b. Is the ischemic blood-brain barrier insufficiency responsible for full-blown Alzheimer's disease? Neurol Res, 28:266-71.
80. Pluta R, Ułamek M, Januszewski S. 2006. Micro-blood-brain barrier openings and cytotoxic fragments of amyloid precursor protein accumulation in white matter after ischemic brain injury in long-lived rats. Acta Neurochir Suppl, 96:267-71.
81. Pluta R. 2007a. Role of ischemic blood-brain barrier on amyloid plaques development in Alzheimer's disease brain. Curr Neurovasc Res, 4:121-9.
82. Pluta R. 2007b. Is the ischemic blood-brain barrier a Trojan horse in Alzheimer's disease brain? In: Pluta R (ed). Ischemia-reperfusion pathways in Alzheimer's disease. New York: Nova Science Publishers, Inc., pp. 139-84.
83. Pluta R. 2007c. Ischemia-reperfusion pathways in Alzheimer's disease. New York: Nova Science Publishers, Inc.
84. Ramsauer M, Krause D, Dermietzel R. 2002. Angiogenesis of the blood-brain barrier in vitro and the function of cerebral pericytes. FASEB J, 16:1274-6.
85. Ritter LS, Stempel KM, Coull BM, et al. 2005. Leukocyte-platelet aggregates in rat peripheral blood after ischemic stroke and reperfusion. Biol Res Nurs, 6:281-8.
86. Sadowski M, Wisniewski HM, Jakubowska-Sadowska K, et al. 1999. Pattern of neuronal loss in the rat hippocampus following experimental cardiac arrest-induced ischemia. J Neurol Sci, 168:13-20.
87. Shi J, Panickar KS, Yang SH, et al. 1998. Estrogen attenuates over-expression of beta-amyloid precursor protein messenger RNA in an animal model of focal ischemia. Brain Res, 810:87-92.
88. Shinnou M, Ueno M, Sakamoto H, et al. 1998. Blood-brain barrier damage in reperfusion following ischemia in the hippocampus of the Mongolian gerbil brain. Acta Neurol Scand, 98:406-11.
89. Simard AR, Soulet D, Gowing G, et al. 2006. Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease. Neuron, 49:489-502.
90. Simpkins JW, Rajakumar G, Zhang YQ, et al. 1997. Estrogens may reduce mortality and ischemic damage caused by middle cerebral artery occlusion in the female rat. J Neurosurg, 87:724-3 0.
91. Sohrabji F. 2007. Guarding the blood-brain barrier: A role for estrogen in the etiology of neurodegenerative disease. Gene Expression, 13:311-9.
92. Spires TL, Hyman BT. 2005. Transgenic models of Alzheimer's disease: learning from animals. NeuroRx, 2:423-37.
93. Stoltzner SE, Grenfell TJ, Mori C, et al. 2000. Temporal accrual of complement proteins in amyloid plaques in Down's syndrome with Alzheimer's disease. Am J Pathol, 156:489-99.
94. Sun X, He G, Qing H, et al. 2006. Hypoxia facilitates Alzheimer's disease pathogenesis by up-regulating BACE1 gene expression. Proc Natl Acad Sci U S A, 103:18727-32.
95. Swerdlow RH. 2007. Is aging part of Alzheimer's disease, or is Alzheimer's disease part of aging. Neurobiol Aging, 28:1465-80.
96. Takuma K, Baba A, Matsuda T. 2004. Astrocyte apoptosis: Implications for neuroprotection. Prog Neurobiol, 72:111-27.
97. Tanimukai H, Imaizumi K, Kudo T, et al. 1998. Alzheimer-associated presenilin-1 gene is induced in gerbil hippocampus after transient ischemia. Mol Brain Res, 54:212-8.
98. Thomas T, Thomas G, McLendon C, et al. 1996. β-amyloid-mediated vaso-activity and vascular endothelial damage. Nature, 380:168-71.
99. Ueno M, Tomimoto H, Akiguchi I, et al. 2002, Blood-brain barrier disruption in white matter lesions in a rat model of chronic cerebral hypoperfusion. J Cereb Blood Flow Metab, 22:97-104.
100. Ujiie M, Dickstein DL, Carlow DA, et al. 2003. Blood-brain barrier permeability precedes senile plaque formation in an Alzheimer disease model. Microcirculation, 10:463-70.
101. Van Groen T, Puurunen K, Maki HM, et al. 2005. Transformation of diffuse beta-amyloid precursor protein and beta-amyloid deposits to plaques in the thalamus after transient occlusion of the middle cerebral artery in rats. Stroke, 36:1551-6.
102. Wen Y, Onyewuchi O, Yang S, et al. 2004. Increased beta-secretase activity and expression in rats following transient cerebral ischemia. Brain Res, 1009:1-8.
103. Wisniewski HM, Pluta R, Lossinsky AS, et al. 1995. Ultrastructural studies of cerebral vascular spasm after cardiac arrest-related global cerebral ischemia in rats. Acta Neuropathol, 90:432-40.
104. Wisniewski HM, Maslinska D. 1996. Beta-protein immunoreactivity in the human brain after cardiac arrest. Folia Neuropathol, 34:65-71.
105. Wolfe MS, Xia W, Ostaszewski BL, et al. 1999. Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and ganima-secretase activity. Nature, 398:513-7.
106. Wyss-Coray T, Loike JD, Brionne TC, et al. 2003. Adult mouse astrocytes degrade amyloid-beta in vitro and in situ. Nat Med, 9:453-7.
107. Yang SH, Liu R, Perez EJ, et al. 2005. Estrogens as protectants of the neurovascular unit against ischemic stroke. Curr Drug Targets CNS Neurol Disord, 4:169-77.
108. Zhang X, Zhou K, Wang R, et al. 2007. Hypoxia-inducible factor 1α (HIF-1α)-mediated hypoxia increases BACE1 expression and β-amyloid generation. J Biol Chem, 282:10873-80.
109. Zipser BD, Johanson CE, Gonzalez L, et al. 2007. Microvascular injury and blood-brain barrier leakage in Alzheimer's disease. Neurobiol Aging, 27:977-86.